TEST

Because lung cancer is not a homogeneous disease...

for
actionable
mutations
 in 
mNSCLC

IDENTIFY

mNSCLC patients with BRAF V600
mutation

ACT

with TAFINLAR + MEKINIST to treat BRAF V600 mNSCLC

TAFINLAR
Summary of Product Characteristics

MEKINIST
Summary of Product Characteristics